10 months ago
PFE
AnalystsRajesh KumarRajesh Kumar's Stock Forecasts
AnalystsRajesh Kumar
Analyst Ranking
Top 30%
#1376 out of 4566 analysts
Average Return
+11.22%
Win Rate
82%9 out of 11
Risk vs Reward
Poor
Good
Rajesh Kumar's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Eli Lilly & CoLLY | +63.20% | $449.46 | $733.51 | 2023-07-14 - 2024-04-26 | Strong Buy |
Teva Pharmaceutical Industries LtdTEVA | +36.33% | $10.13 | $13.81 | 2023-12-18 - 2024-04-26 | Strong Buy |
Bristol Myers Squibb CoBMY | +17.63% | $61.94 | $51.02 | 2023-07-14 - 2023-10-27 | Sell |
Unitedhealth Group IncUNH | +13.52% | $526.55 | $455.38 | 2023-12-18 - 2024-04-04 | Sell |
Abbvie IncABBV | +12.80% | $136.01 | $153.42 | 2023-07-14 - 2023-12-18 | Strong Buy |
Rajesh Kumar Analyst Color
Get additional color on Rajesh Kumar's coverage of popular stocks
10 months ago
LLY
Rajesh Kumar's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Thermo Fisher Scientific IncTMO | 2 | Strong Buy | $660.00 | +15.06% | Maintains | 12 days ago |
Danaher CorpDHR | 1 | Strong Buy | $280.00 | +13.55% | Upgrades | 12 days ago |
Unitedhealth Group IncUNH | 2 | Hold | $460.00 | -7.14% | Upgrades | 25 days ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Strong Buy | $13.00 | -5.87% | Initiates Coverage On | 4 months ago |
Abbvie IncABBV | 2 | Hold | $156.00 | -2.27% | Downgrades | 4 months ago |
Bristol Myers Squibb CoBMY | 2 | Hold | $53.00 | +18.17% | Upgrades | 6 months ago |
Moderna IncMRNA | 1 | Sell | $97.00 | -10.16% | Initiates Coverage On | 10 months ago |
Biontech SeBNTX | 1 | Strong Buy | $124.00 | +42.19% | Initiates Coverage On | 10 months ago |
Pfizer IncPFE | 1 | Strong Buy | $50.00 | +96.85% | Initiates Coverage On | 10 months ago |
Merck & Co IncMRK | 1 | Hold | $123.00 | -6.25% | Initiates Coverage On | 10 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $560.00 | -23.65% | Initiates Coverage On | 10 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.